| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_207c148d0cfc11d05383db5abcce58d3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2020-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_382ea6ad32ccb1b046163a2ab2b26e46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_937c8e9395fd4e0f5726526408aef89d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a797015aa7a483b011858f63637f2933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e0ed5d784bcafaee86f46617256f051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76e2b04450b5409495250b0411e9f2b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e524b952b42362cb0490f5e62b3683d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bb85c6ce9b96337073c76441c7cf8f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e908632d4efb2f1f82e86d7a1cfb814f |
| publicationDate |
2021-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021123165-A1 |
| titleOfInvention |
Dosage form comprising amorphous solid solution of empagliflozin with polymer |
| abstract |
The invention provides solid pharmaceutical dosage forms and methods for making the same, wherein the pharmaceutical dosage forms comprise Empagliflozin in the form of an amorphous solid solution with at least one polymer. The pharmaceutical dosage forms according to the invention exhibit excellent stability especially in terms of physical stabilization of amorphous form of Empagliflozin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618495-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618495-B |
| priorityDate |
2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |